Literature DB >> 21558424

Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3.

Xiaoming Wang1, Portia A McCoy, Ramona M Rodriguiz, Yanzhen Pan, H Shawn Je, Adam C Roberts, Caroline J Kim, Janet Berrios, Jennifer S Colvin, Danielle Bousquet-Moore, Isabel Lorenzo, Gangyi Wu, Richard J Weinberg, Michael D Ehlers, Benjamin D Philpot, Arthur L Beaudet, William C Wetsel, Yong-Hui Jiang.   

Abstract

SHANK3 is a synaptic scaffolding protein enriched in the postsynaptic density (PSD) of excitatory synapses. Small microdeletions and point mutations in SHANK3 have been identified in a small subgroup of individuals with autism spectrum disorder (ASD) and intellectual disability. SHANK3 also plays a key role in the chromosome 22q13.3 microdeletion syndrome (Phelan-McDermid syndrome), which includes ASD and cognitive dysfunction as major clinical features. To evaluate the role of Shank3 in vivo, we disrupted major isoforms of the gene in mice by deleting exons 4-9. Isoform-specific Shank3(e4-9) homozygous mutant mice display abnormal social behaviors, communication patterns, repetitive behaviors and learning and memory. Shank3(e4-9) male mice display more severe impairments than females in motor coordination. Shank3(e4-9) mice have reduced levels of Homer1b/c, GKAP and GluA1 at the PSD, and show attenuated activity-dependent redistribution of GluA1-containing AMPA receptors. Subtle morphological alterations in dendritic spines are also observed. Although synaptic transmission is normal in CA1 hippocampus, long-term potentiation is deficient in Shank3(e4-9) mice. We conclude that loss of major Shank3 species produces biochemical, cellular and morphological changes, leading to behavioral abnormalities in mice that bear similarities to human ASD patients with SHANK3 mutations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558424      PMCID: PMC3131048          DOI: 10.1093/hmg/ddr212

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  57 in total

Review 1.  Autism spectrum disorders.

Authors:  C Lord; E H Cook; B L Leventhal; D G Amaral
Journal:  Neuron       Date:  2000-11       Impact factor: 17.173

2.  Synaptic scaffolding proteins in rat brain. Ankyrin repeats of the multidomain Shank protein family interact with the cytoskeletal protein alpha-fodrin.

Authors:  T M Böckers; M G Mameza; M R Kreutz; J Bockmann; C Weise; F Buck; D Richter; E D Gundelfinger; H J Kreienkamp
Journal:  J Biol Chem       Date:  2001-08-16       Impact factor: 5.157

3.  Disruption of the ProSAP2 gene in a t(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome.

Authors:  M C Bonaglia; R Giorda; R Borgatti; G Felisari; C Gagliardi; A Selicorni; O Zuffardi
Journal:  Am J Hum Genet       Date:  2001-06-18       Impact factor: 11.025

Review 4.  AMPA receptor trafficking at excitatory synapses.

Authors:  David S Bredt; Roger A Nicoll
Journal:  Neuron       Date:  2003-10-09       Impact factor: 17.173

5.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation.

Authors:  Simone Berkel; Christian R Marshall; Birgit Weiss; Jennifer Howe; Ralph Roeth; Ute Moog; Volker Endris; Wendy Roberts; Peter Szatmari; Dalila Pinto; Michael Bonin; Angelika Riess; Hartmut Engels; Rolf Sprengel; Stephen W Scherer; Gudrun A Rappold
Journal:  Nat Genet       Date:  2010-05-16       Impact factor: 38.330

6.  Aberrant responses in social interaction of dopamine transporter knockout mice.

Authors:  Ramona M Rodriguiz; Richard Chu; Marc G Caron; William C Wetsel
Journal:  Behav Brain Res       Date:  2004-01-05       Impact factor: 3.332

7.  FISH-mapping of a 100-kb terminal 22q13 deletion.

Authors:  Britt-Marie Anderlid; Jacqueline Schoumans; Göran Annerén; Isabel Tapia-Paez; Jan Dumanski; Elisabeth Blennow; Magnus Nordenskjöld
Journal:  Hum Genet       Date:  2002-04-04       Impact factor: 4.132

8.  Linkage of the actin cytoskeleton to the postsynaptic density via direct interactions of Abp1 with the ProSAP/Shank family.

Authors:  Britta Qualmann; Tobias M Boeckers; Monika Jeromin; Eckart D Gundelfinger; Michael M Kessels
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

9.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

Review 10.  The Shank family of scaffold proteins.

Authors:  M Sheng; E Kim
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

View more
  248 in total

1.  Modifier genetics in neuropsychiatric disease: challenges and opportunities.

Authors:  Elizabeth K Ruzzo; Andrea L Pappas; David B Goldstein
Journal:  Genome Biol       Date:  2012       Impact factor: 13.583

Review 2.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders.

Authors:  Sacha B Nelson; Vera Valakh
Journal:  Neuron       Date:  2015-08-19       Impact factor: 17.173

Review 3.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

Review 4.  Induced pluripotent stem cells for modeling neurological disorders.

Authors:  Fabiele B Russo; Fernanda R Cugola; Isabella R Fernandes; Graciela C Pignatari; Patricia C B Beltrão-Braga
Journal:  World J Transplant       Date:  2015-12-24

5.  SHANK Mutations May Disorder Brain Development.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2015-02

6.  Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects.

Authors:  Yang Zhou; Tobias Kaiser; Patrícia Monteiro; Xiangyu Zhang; Marie S Van der Goes; Dongqing Wang; Boaz Barak; Menglong Zeng; Chenchen Li; Congyi Lu; Michael Wells; Aldo Amaya; Shannon Nguyen; Michael Lewis; Neville Sanjana; Yongdi Zhou; Mingjie Zhang; Feng Zhang; Zhanyan Fu; Guoping Feng
Journal:  Neuron       Date:  2015-12-10       Impact factor: 17.173

Review 7.  The genetics of Autism Spectrum Disorders--a guide for clinicians.

Authors:  Karsten M Heil; Christian P Schaaf
Journal:  Curr Psychiatry Rep       Date:  2013-01       Impact factor: 5.285

8.  Cerebellar and posterior fossa malformations in patients with autism-associated chromosome 22q13 terminal deletion.

Authors:  Kimberly A Aldinger; Jillene Kogan; Virginia Kimonis; Bridget Fernandez; Denise Horn; Eva Klopocki; Brian Chung; Annick Toutain; Rosanna Weksberg; Kathleen J Millen; A James Barkovich; William B Dobyns
Journal:  Am J Med Genet A       Date:  2012-12-07       Impact factor: 2.802

Review 9.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

Review 10.  Therapeutic approaches for shankopathies.

Authors:  Xiaoming Wang; Alexandra L Bey; Leeyup Chung; Andrew D Krystal; Yong-Hui Jiang
Journal:  Dev Neurobiol       Date:  2013-10-11       Impact factor: 3.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.